COMPREHENSIVE WORKFLOW FOR QUANTITATIVE BIOANALYSIS OF LARGE PEPTIDES AND PROTEINS: A CASE STUDY OF THE GLP-1 RECEPTOR AGONIST, SEMAGLUTIDE, IN PLASMA Authors: Samantha Ferries1, Suraj Dhungana1, Robert S Plumb2Amy Bartlett 1 Affiliations: 1 WatersTM Corporation, Wilmslow, UK, 2 Waters Corporation,…
Application Note Comprehensive Workflow for the Quantification of Peptides and Proteins in Plasma: Semaglutide– a Case Study Samantha Ferries Waters Corporation, United States Published on November 11, 2025 Abstract Over the last two decades, there has been a significant increase…
[ APPLICATION NOTEBOOK ] Versatile LC-MS/MS Solutions for the Evolving Bioanalysis Landscape Small Molecules Oligonucleotide Protein/Peptide Therapeutics Software Tools Targeted Imaging LC-MS/MS Solutions to Support Reliable, Sensitive and Efficient Workflows for the Bioanalysis of Drug Modalities Welcome to the Waters…
Application Note Developing a Quantitative Surrogate Peptide Assay – Peptide mapping through MRM Optimization for Measuring Dulaglutide in a Rat PK Study Caitlin Dunning, Mark Wrona Waters Corporation Abstract Development of fusion protein therapeutics, such as dulaglutide (TRULICITYTM), is rising…
